BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02640209-completion@plaintrial.com
DTSTAMP:20260928T002303Z
DTSTART;VALUE=DATE:20190716
SUMMARY:Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 C
 himeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients
  With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Sm
 all Lymphocytic Lymphoma (SLL) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02640209
URL:https://plaintrial.com/trial/NCT02640209
END:VEVENT
END:VCALENDAR